News Pharmadrug Inc.

Equities

PHRX

CA71716W2040

Delayed Canadian Securities Exchange Other stock markets 09:06:57 16/05/2024 pm IST			5-day change	1st Jan Change
0.035 ^CAD	0.00%		+16.67%	-36.36%

15/05	PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	MT
01/05	PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	15/05	MT
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine	15/05	NE
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization	13/05	NE
PharmaDrug Announces Director Appointment and Resignation	03/05	NE
PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	01/05	MT
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	01/05	NE
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	16/04	NE
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	16/04	MT
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13/03	CI
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13/03	NE
PharmaDrug Inc Announces Board Changes	28/02	CI
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	27/02	NE
PharmaTher Provides Update For PD-001	21/02	MT
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	14/02	NE
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc	12/02	CI
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	12/02	NE
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	09/02	NE
Pharmadrug Inc. announced that it has received CAD 0.326 million in funding	08/02	CI
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement	01/02	NE
Pharmadrug Inc. announced that it expects to receive CAD 0.326 million in funding	01/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmadrug Inc.

Equities

PHRX

CA71716W2040

Summary

Filters